Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P61278 (
somatostatin
)
22,083
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The action of serotonin on growth hormone (GH) secretion is controversial because of interspecies differences and lack of specificity of serotoninergic drugs. Serotonin (5-HT) appears to inhibit GH release in the sheep and in man. We have investigated the site of action of tianeptine, a 5-HT uptake enhancer, in sheep since it is possible to collect hypophysial portal blood for the simultaneous determination of growth hormone-releasing hormone (GHRH) and
somatostatin
in this species under conscious, unstressed conditions.
Tianeptine
injection (10 mg/kg i.v.) resulted in a significant, immediate and short-lasting (30 min) increase in peripheral GH (+750%; P < 0.01) and hypophysial portal GHRH (+180%; P < 0.01). No change in the secretion of
somatostatin
was recorded during the same time. These data suggest that serotoninergic inputs are inhibitory to GH secretion.
Tianeptine
acts centrally to stimulate GH secretion in the sheep and its effect is mediated through changes in GHRH but not
somatostatin
release into hypophysial portal blood.
...
PMID:Effect of tianeptine on the hypothalamic somatotropic axis in the conscious sheep. 791 95